Quillichew ER vs. Aptensio XR

Are Quillichew ER and Aptensio XR the Same Thing?

QuilliChew ER (methylphenidate hydrochloride) extended-release chewable tablets and Aptensio XR (methylphenidate hydrochloride extended-release) are central nervous system (CNS) stimulants used to treat attention deficit hyperactivity disorder (ADHD).

Side effects of QuilliChew ER and Aptensio XR that are similar include dizziness, rapid heart rate, decreased appetite, headache, nausea, vomiting, abdominal pain, sleep problems (insomnia), and fever.

Side effects of QuilliChew ER that are different from Aptensio XR include weight loss, anxiety, irritability, mood swings, aggression, indigestion, dry mouth, nervousness, restlessness, agitation, spinning sensation (vertigo), tremor, blurred vision, palpitations, increased sweating, and increased blood pressure.

Both QuilliChew ER and Aptensio XR may interact with monoamine oxidase inhibitors (MAOIs).

Withdrawal symptoms may occur if you suddenly stop taking QuilliChew ER or Aptensio XR.

What Are Possible Side Effects of Quillichew ER?

Common side effects of Quillichew ER include:

  • weight loss,
  • anxiety,
  • dizziness,
  • irritability,
  • mood swings,
  • rapid heart rate,
  • decreased appetite,
  • aggression,
  • headache,
  • nausea,
  • abdominal pain,
  • indigestion,
  • dry mouth,
  • vomiting,
  • insomnia,
  • nervousness,
  • restlessness,
  • agitation,
  • spinning sensation (vertigo),
  • tremor,
  • blurred vision,
  • palpitations,
  • increased sweating,
  • fever, and
  • increased blood pressure.

What Are Possible Side Effects of Aptensio XR?

Common side effects of Aptensio XR include:

  • abdominal pain,
  • fever,
  • decreased appetite,
  • nausea,
  • vomiting,
  • headache,
  • insomnia,
  • dizziness, and
  • rapid heart rate

QUESTION

The abbreviated term ADHD denotes the condition commonly known as: See Answer

What Is Quillichew ER?

QuilliChew ER (methylphenidate hydrochloride) extended-release chewable tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

What Is Aptensio XR?

Aptensio XR (methylphenidate hydrochloride extended-release) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

What Drugs Interact With Quillichew ER?

QuilliChew ER may interact with monoamine oxidase inhibitors (MAOIs). Tell your doctor all medications and supplements you or your child uses. During pregnancy, QuilliChew ER should be used only if prescribed. It is unknown if it would affect a fetus. QuilliChew ER passes into breast milk. It is unknown if it would affect a nursing infant. Consult your doctor before breastfeeding. Withdrawal symptoms may occur if you suddenly stop taking QuilliChew ER.

What Drugs Interact With Aptensio XR?

Aptensio XR may interact with monoamine oxidase inhibitors (MAOIs). Tell your doctor all medications and supplements you use. During pregnancy, Aptensio XR should be used only if prescribed. Premature delivery and low birth weight infants have been reported in amphetamine-dependent mothers. Aptensio XR passes into breast milk and may have undesirable effects on a nursing infant. Consult your doctor before breastfeeding. Withdrawal symptoms may occur if you suddenly stop taking Aptensio XR.

SLIDESHOW

ADHD Symptoms in Children See Slideshow

How Should Quillichew ER Be Taken?

For patients 6 years and above, the recommended starting dose of QuilliChew ER is 20 mg given orally once daily in the morning.

How Should Aptensio XR Be Taken?

The recommended starting dose of Aptensio XR for patients 6 years and above is 10 mg once daily with or without food in the morning. Dosage may be increased weekly in increments of 10 mg per day. Daily dosage above 60 mg is not recommended.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
SOURCE:

NextWave Pharmaceuticals, Inc. Quillichew ER Product Information.

https://www.quillivantxr-quillichewer.com/

Rhodes Pharmaceuticals L.P. Aptensio XR Product Information.

https://www.adzenysxrodt.com/about-adzenys/how-to-take-adzenys

Health Solutions From Our Sponsors